Relmada Therapeutics Ownership | Who Owns Relmada Therapeutics?
Relmada Therapeutics Ownership Summary
Relmada Therapeutics is owned by 20.45% institutional investors, 17.03% insiders, and 62.52% retail investors. Franklin resources is the largest institutional shareholder, holding 4.32% of RLMD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.57% of its assets in Relmada Therapeutics shares.
RLMD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Relmada Therapeutics | 20.45% | 17.03% | 62.52% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
| Idea | Psychedelic Stocks List | 41.70% | 15.31% | 42.99% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Franklin resources | 1.30M | 4.32% | $677.12K |
| Vanguard group | 1.26M | 4.16% | $653.49K |
| Acadian asset management | 1.23M | 4.07% | $636.00K |
| Blackrock funding, inc. /de | 593.33K | 1.97% | $308.53K |
| Blackrock | 573.31K | 1.90% | $1.72M |
| Palo alto investors lp | 495.15K | 1.64% | $257.48K |
| Geode capital management | 302.84K | 1.00% | $157.52K |
| Deutsche bank ag\ | 224.85K | 0.75% | $116.92K |
| Ubs group | 215.14K | 0.71% | $111.87K |
| Advisorshares investments | 210.07K | 0.70% | $109.23K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Spotlight asset group | 20.00K | 0.04% | $60.00K |
| Palo alto investors lp | 495.15K | 0.04% | $257.48K |
| Advisorshares investments | 210.07K | 0.02% | $109.23K |
| Apricus wealth | 48.96K | 0.02% | $25.46K |
| Parsons capital management inc/ri | 163.34K | 0.00% | $84.94K |
| Bedel financial consulting | 10.00K | 0.00% | $30.00K |
| Rbf capital | 163.26K | 0.00% | $84.90K |
| Ikarian capital | 40.27K | 0.00% | $20.94K |
| Mgo one seven | 100.00K | 0.00% | $52.00K |
| Acadian asset management | 1.23M | 0.00% | $636.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Advisorshares investments | 210.07K | 0.02% | 141.54K |
| Renaissance | 164.51K | 0.00% | 138.63K |
| Ubs group | 215.14K | - | 88.75K |
| Acadian asset management | 1.23M | 0.00% | 41.48K |
| Blackrock funding, inc. /de | 593.33K | - | 25.45K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Parsons capital management inc/ri | 163.34K | 0.00% | -839.36K |
| Deep track capital, lp | - | - | -674.83K |
| Vestal point capital, lp | - | - | -490.00K |
| Opaleye management | - | - | -480.00K |
| Jpmorgan chase | 37.70K | - | -277.36K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Robertson stephens wealth management | 25.00K | 0.00% | 25.00K | $13.00K |
| Bnp paribas arbitrage, snc | 72.00 | - | 72.00 | $37.00 |
Sold Out
| Holder | Change |
|---|---|
| Blackston financial advisory group | -2.00 |
| Innealta capital | -5.00 |
| Front row advisors | -6.00 |
| Smartleaf asset management | -35.00 |
| Qube research | -56.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 44 | -15.38% | 6,219,493 | -25.95% | 20 | 2.64% | 12 | -36.84% | 14 | -33.33% |
| Dec 31, 2024 | 20 | -73.68% | 5,351,011 | -56.77% | 17 | 1.05% | 6 | -70.00% | 8 | -68.00% |
| Sep 30, 2024 | 76 | -9.52% | 12,376,687 | -8.70% | 41 | 2.03% | 20 | -4.76% | 25 | -21.88% |
| Jun 30, 2024 | 83 | -15.31% | 13,556,139 | -5.26% | 44 | 1.99% | 21 | -48.78% | 31 | 24.00% |
| Mar 31, 2024 | 98 | 11.36% | 14,308,498 | 5.06% | 47 | 2.32% | 41 | 2.50% | 25 | 25.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 851.92K | 2.57% | - |
| Vanguard Total Stock Mkt Idx Inv | 803.29K | 2.42% | -48.63K |
| Franklin Biotechnology Discv A(acc)USD | 623.80K | 2.07% | -221.90K |
| Franklin Biotechnology Discovery A | 336.31K | 1.11% | -120.09K |
| Vanguard Institutional Extnd Mkt Idx Tr | 353.63K | 1.07% | - |
| AdvisorShares Psychedelics ETF | 326.51K | 0.98% | - |
| Horizons Psychedelic Stock ETF | 227.04K | 0.75% | -36.13K |
| Fidelity Extended Market Index | 160.83K | 0.48% | 9.36K |
| Bridgeway Ultra-Small Company | 100.18K | 0.33% | - |
| Fidelity Enhanced Small Cap ETF | 92.92K | 0.31% | 1.75K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Kelly Paul Edward | Chief Operating Officer | Buy | $86.06K |
| May 19, 2025 | Shenouda Maged | Chief Financial Officer | Buy | $43.69K |
| May 20, 2025 | Shenouda Maged | Chief Financial Officer | Buy | $31.42K |
| May 16, 2025 | Shenouda Maged | Chief Financial Officer | Buy | $22.10K |
| May 16, 2025 | Ence Chuck | CA and CO | Buy | $103.33K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 8 | - |
| 2024 Q4 | - | - |
| 2024 Q3 | 8 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | 9 | - |
RLMD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools